Opioids and immune modulation: more questions than answers

Area of Science:

• Immunology
• Pharmacology
• Neuroscience

Background:

• Opioid addiction is frequently associated with infections, suggesting opioids influence immune responses.
• The precise mechanisms and cellular targets of opioid-induced immune modulation are poorly understood and debated.
• Current hypotheses involve direct immune cell actions, the hypothalamic-pituitary-adrenal (HPA) axis, or other central/sympathetic nervous system pathways.

Purpose of the Study:

• To critically evaluate the existing literature on opioid-induced immune modulation.
• To identify the cellular targets and mechanisms responsible for opioid effects on the immune system.
• To highlight discrepancies between animal and human studies and advocate for clinical research.

Main Methods:

• Literature review and critical analysis of existing studies on opioid-receptor interactions and immune function.
• Examination of evidence for opioid receptors on immune cells.
• Assessment of data regarding HPA axis activation by opioids.
• Consideration of alternative targets like the sympathetic nervous system.

Main Results:

• Classical opioid receptors (MOP, DOP, KOP) are not consistently found on immune cells.
• Evidence for significant HPA axis activation by clinically relevant opioids is weak and species-dependent.
• Most common opioids do not target the NOP receptor, a naloxone-insensitive receptor.
• The cellular targets and mechanisms of opioid immune modulation remain undefined.

Conclusions:

• The cellular targets for opioid-induced immune modulation are not well-defined by current research.
• Existing evidence does not strongly support direct action on immune cells or significant HPA axis involvement for common opioids.
• Further investigation, particularly in clinical settings, is necessary to elucidate opioid effects on human immune function.